Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-02

Clinical Trial Update: Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection [NA]

View source ↗

Summary

The document summarizes completion of a non-investigational study evaluating adenovirus serotype 5 neutralizing antibodies in patients with chronic hepatitis B …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenovirus Serotype 5 (Ad5) neutralizing antibodies

Snippet

Sponsor: Transgene | Conditions: Chronic Hepatitis B | NA | Status: COMPLETED